The NCCP in conjunction with the NCEC has published a National evidence-based Clinical Guideline on Prostate Cancer.
The Guideline is available to download in PDF format (1.82MB) HERE.
A summary of the guideline is also available in PDF format (743KB) HERE.
- Aim to improve the quality of clinical care,
- Aim to prevent variation in practice,
- Aim to address areas of clinical care with new and emerging evidence,
- They are based on the best research evidence in conjunction with clinical expertise,
- They are developed using a clear evidence-based internationally used methodology.
A Guideline Development Group was responsible for the development of this National Clinical Guideline and included representatives from relevant professional groups. The guideline focuses on the diagnosis, staging and treatment of patients with prostate cancer. It does not include recommendations covering every aspect of diagnosis, staging and treatment. Instead this guideline focuses on areas of clinical practice:
- known to be controversial or uncertain,
- where there is identifiable variation in practice,
- where there is new or emerging evidence,
- where guidelines have potential to have the most impact.
This evidence-based clinical guideline will ensure standardised multidisciplinary care for patients, putting evidence into practice to improve patient outcomes.
Comments should be emailed to email@example.com.
(note on page 9 of this guideline, reference is made to accompanying documents - not all of these are available on the website yet and will be uploaded shortly)
last updated June 27th 2017.